Ajax-Loading

Merck & Company Inc - Other Long Term Liabilities

Merck & Company Inc's Fiscal Year is From January To December - All Figures are in USD, Billions.

The item "Other-Long-Term-Liabilities" stands at 7.66 Billion United States Dollars as of 09/30/2025, the highest value since 06/30/2024.

As of the end of Merck & Company Inc's third quarter, the item "Other Long Term Liabilities" stands at 7.66 Billion USD. This represents an increase of 8.96 percent compared to it's value at the end of it's second quarter .


Regarding the One-Year-Change of the series, the current value constitutes an increase of 1.60 percent compared to the value the year prior.
The 1 year change in percent is 1.60.
The 3 year change in percent is -11.54.
The 5 year change in percent is -36.30.
The 10 year change in percent is -2.87.

The Serie's long term average value is 9.15 Billion United States Dollars. It's latest available value, on 09/30/2025, is 16.29 percent lower, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 12/31/2024, to it's latest available value, on 09/30/2025, is +18.50%.
The Serie's change in percent from it's maximum value, on 12/31/2020, to it's latest available value, on 09/30/2025, is -38.62%.

Other Long Term Liabilities for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Other Long Term Liabilities905,699,262,464.00
LogoJohnson & Johnson - Other Long Term Liabilities486,508,953,600.00
LogoAbbVie Inc - Other Long Term Liabilities399,570,305,024.00
LogoRoche Holding AG - Other Long Term Liabilities317,433,206,677.55
LogoAstraZeneca PLC - Other Long Term Liabilities280,205,508,085.11